⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

February 2, 2026European Journal of Clinical Microbiology & Infectious Diseases

In vitro activity of furazidin and comparator agents against bacterial isolates from urinary tract infections

Justyna Maszkowska Agnieszka Denkis Mariana Castanheira Helio S. Sader Dariusz Pawelec

View at Publisher

Ask AI

Bookmark

Share

Key Points

Furazidin demonstrated significant in vitro activity against common bacterial isolates.
The study included a variety of comparator agents to assess effectiveness against urinary pathogens.
Assessment of antimicrobial activity was conducted using standardized laboratory techniques.
These findings highlight the potential of furazidin for treating urinary tract infections, pending further evaluation.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

Observational analysis reveals antibacterial activity of furazidin against urinary tract infection isolates, suggesting therapeutic potential.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Maszkowska et al. (2026) studied this question.

synapsesocial.com/papers/69a76582badf0bb9e87d95b8 https://doi.org/10.1007/s10096-026-05418-3

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Epidemiological trends and predictions of urinary tract infections in the global burden of disease study 2021Original Research · 2025 · 97 citations
2Global epidemiology of urinary tract infectionsReview · 2015 · 427 citations
3A global perspective on improving patient care in uncomplicated urinary tract infection: expert consensus and practical guidanceClinical Trial · 2021 · 61 citations
4Nitrofuran Derivatives Cross-Resistance Evidence—Uropathogenic Escherichia coli Nitrofurantoin and Furazidin In Vitro Susceptibility TestingOriginal Research · 2023 · 12 citations
5Antibiotic Resistance Among Uropathogenic <i>Escherichia coli</i>Review · 2019 · 278 citations

International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases2011
Multidirectional Efficacy of Biologically Active Nitro Compounds Included in Medicines2018
Antimicrobial resistance of pathogens causing community-acquired urinary tract infections in Russia: results of the multicenter study “DARMIS-2018”2019
The prognostic value of a laboratory-based frailty index (FI-Lab) in carbapenem-resistant Acinetobacter baumannii infections: a multicentre cohort studyEuropean Journal of Clinical Microbiology & Infectious Diseases · 2026
Desensitisation protocol for ethambutol in the treatment of Mycobacterium avium complex pulmonary diseaseEuropean Journal of Clinical Microbiology & Infectious Diseases · 2026

More from European Journal of Clinical Microbiology & Infectious Diseases

More from JMI Laboratories

More from Adamed (Poland)